Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Denman, A. M.
Right arrow Articles by Black, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Denman, A. M.
Right arrow Articles by Black, C.
Related Collections
Right arrow Systemic Sclerosis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 1192
© 2001 British Society for Rheumatology

Letters to the Editor

Anti-thymocyte globulin in scleroderma

A. M. Denman

Gaters, Old Shire Lane, Chorleywood, Hertfordshire WD3 5PW, UK

SIR, The detailed study of aggressive immunosuppressive treatment of scleroderma by Stratton et al. [1] is of great interest. Certainly novel approaches are justified in a . . . [Full Text of this Article]

References

R. Stratton, H. Wilson and C. Black

Department of Rheumatology, Royal Free and University College Medical School, University College London, London NW3 2PF, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?